NEBACUMAB
UNII 908FWN27WK

Substance Identification & Data

This profile provides standardized clinical and technical data for Nebacumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 908FWN27WK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 138661-01-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
908FWN27WK
CAS Registry Number
138661-01-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
NEBACUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
6658
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
BB-74
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nebacumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NEBACUMAB

Common Names & Synonyms

IMMUNOGLOBULIN M (HUMAN MONOCLONAL HA-1A ANTI-ENDOTOXIN), DISULFIDE WITH HUMAN MONOCLONAL HA-1A K-CHAIN, PENTAMERIC DIMER
NEBACUMAB [INN]
NEBACUMAB [USAN]
NEBACUMAB [WHO-DD]
SEPTOMONAB

Brand / Trade Names

CENTOXIN

Technical Codes

HA 1A
HA-1A